Changes in cerebrospinal fluid interleukin-10 levels display better performance in predicting disease relapse than conventional magnetic resonance imaging in primary central nervous system lymphoma

HIGHLIGHTS

• who: Yan Zhang from the Department of Hematology, Peking Union Medical College Hospital, Beijing, China have published the paper: Changes in cerebrospinal fluid interleukin-10 levels display better performance in predicting disease relapse than conventional magnetic resonance imaging in primary central nervous system lymphoma, in the Journal: (JOURNAL) of September/10,/2019
• what: This study evaluated the value of dynamic interleukin (IL)-10 cerebrospinal fluid (CSF) concentrations for prognosis and relapse prediction in PCNSL. The authors focused on the precedence relationship of elevated CSF IL-10 concentration and positive magnetic_resonance imaging (MRI) findings in relapse . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.